CO - Global Cord Blood Corporation

NYSE - NYSE Delayed Price. Currency in USD

Global Cord Blood Corporation

Bank of China Tower
48th Floor 1 Garden Road
Hong Kong
852 3605 8180

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Ms. Ting ZhengChairman, CEO & Interim CEO of Beijing DivisionN/AN/A1972
Mr. Albert ChenCFO & DirectorN/AN/A1976
Ms. Xin XuChief Technology OfficerN/AN/A1954
Ms. Rui ArashiyamaChief Exec. Officer of Guangdong Division & Zhejiang DivisionN/AN/A1959
Ms. Cathy BaiVP of Corp. Fin.N/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).

Corporate Governance

Global Cord Blood Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.